What is the ROCE (Return on Capital Employed) of Sesen Bio this year?
The ROCE of Sesen Bio is 0.09 undefined this year.
Sesen Bio ROCE 2024
Sesen Bio ROCE
0.09
Ticker
SESN
ISIN
US8177631053
WKN
A2JL47
In 2024, Sesen Bio's return on capital employed (ROCE) was 0.09, a -48.45% increase from the 0.17 ROCE in the previous year.
Sesen Bio Aktienanalyse
What does Sesen Bio do?
Sesen Bio Inc. is a biotechnology company focused on developing advanced therapeutics for the treatment of cancer and other challenging diseases. The company was founded in 2010 in Cambridge, Massachusetts, and has since expanded its research and development efforts to develop a range of therapies based on its innovative technologies and approaches. The goal of Sesen Bio is to develop groundbreaking drugs and therapies that are both safe and effective, helping patients successfully fight their illness. The company's focus is on unlocking new treatment possibilities through its proprietary platforms, including its antibody-drug conjugate (ADC) technology, on which all drug candidates are based. Sesen Bio has three main divisions: cancer treatment, therapy development, and partnership program. The cancer treatment division focuses on clinical trials and product marketing. This is where the first approved drug, Vicinium, is mentioned. Vicinium is an ADC consisting of a monoclonal antibody against prostate-specific membrane antigen (PSMA). It is indicated for the treatment of patients with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). The therapy development division is involved in creating drug candidates and advancing their development through clinical trials. The partnership program allows Sesen Bio to license and commercialize its technologies and platforms by partnering with other biotechnology companies and pharmaceutical companies. The company has made significant progress in the development of therapeutics in recent years. The first approved drug, Vicinium, has propelled the company forward. The company is conducting clinical trials on other drug candidates to evaluate their efficacy and safety. Additionally, the company has a pipeline of new products in various stages of development, including NG-348, a novel ADC targeting the epidermal growth factor receptor (EGFR) that can be used in the treatment of solid tumors in various organs. Sesen Bio aims to further expand its innovative technologies in the field of cancer therapy and expand its offering of groundbreaking therapeutics. The company works closely with its partners and customers to develop customized treatment solutions and ensure high patient satisfaction. With its dedicated research and development department, well-established partnerships, and ability to make groundbreaking technologies widely available, Sesen Bio is on track to become a leading company in the field of cancer therapy. Overall, Sesen Bio is an innovative biotechnology company dedicated to developing therapeutics that improve the lives of patients with cancer and other serious diseases. Through its proprietary technologies and platforms, dedicated research and development departments, and well-established partnerships, the company has established itself as a key player in the field of cancer therapy. Sesen Bio is a company with a vision and a mission that permeate everything it does, namely saving and improving lives. Sesen Bio ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROCE Details
Unraveling Sesen Bio's Return on Capital Employed (ROCE)
Sesen Bio's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.
Year-to-Year Comparison
Analyzing Sesen Bio's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.
Impact on Investments
Sesen Bio's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.
Interpreting ROCE Fluctuations
Changes in Sesen Bio’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.
Frequently Asked Questions about Sesen Bio stock
How has the ROCE (Return on Capital Employed) of Sesen Bio developed compared to the previous year?
The ROCE of Sesen Bio has increased by -48.45% decreased compared to the previous year.
What does a high ROCE (Return on Capital Employed) mean for investors of Sesen Bio?
A high Return on Capital Employed (ROCE) indicates that Sesen Bio has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.
What does a low ROCE (Return on Capital Employed) mean for investors of Sesen Bio?
A low ROCE (Return on Capital Employed) can indicate that Sesen Bio has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.
How does an increase in ROCE from Sesen Bio impact the company?
An increase in the ROCE of Sesen Bio can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.
How does a reduction in the ROCE of Sesen Bio affect the company?
A decrease in ROCE of Sesen Bio can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.
What are some factors that can influence the ROCE of Sesen Bio?
Some factors that can affect Sesen Bio's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.
Why is the ROCE of Sesen Bio so important for investors?
The ROCE of Sesen Bio is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.
What strategic measures can Sesen Bio take to improve the ROCE?
To improve the ROCE, Sesen Bio can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.
How much dividend does Sesen Bio pay?
Over the past 12 months, Sesen Bio paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Sesen Bio is expected to pay a dividend of 0 USD.
What is the dividend yield of Sesen Bio?
The current dividend yield of Sesen Bio is .
When does Sesen Bio pay dividends?
Sesen Bio pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Sesen Bio?
Sesen Bio paid dividends every year for the past 0 years.
What is the dividend of Sesen Bio?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Sesen Bio located?
Sesen Bio is assigned to the 'Health' sector.
Wann musste ich die Aktien von Sesen Bio kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Sesen Bio from 10/5/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/5/2024.
When did Sesen Bio pay the last dividend?
The last dividend was paid out on 10/5/2024.
What was the dividend of Sesen Bio in the year 2023?
In the year 2023, Sesen Bio distributed 0 USD as dividends.
In which currency does Sesen Bio pay out the dividend?
The dividends of Sesen Bio are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Sesen Bio stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Sesen Bio
Our stock analysis for Sesen Bio Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sesen Bio Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
